Cargando…
New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy
Despite rapid advances in the field of immunotherapy, the elimination of established tumors has not been achieved. Many promising new treatments such as adoptive cell therapy (ACT) fall short, primarily due to the loss of T cell effector function or the failure of long-term T cell persistence. With...
Autores principales: | Oberholtzer, Nathaniel, Quinn, Kristen M., Chakraborty, Paramita, Mehrotra, Shikhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870179/ https://www.ncbi.nlm.nih.gov/pubmed/35203357 http://dx.doi.org/10.3390/cells11040708 |
Ejemplares similares
-
CD38-NAD(+)-Sirt1 axis in T cell immunotherapy
por: Chatterjee, Shilpak, et al.
Publicado: (2019) -
Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy
por: Lian, Xin, et al.
Publicado: (2022) -
New Developments in T Cell Immunometabolism and Therapeutic Implications for Type 1 Diabetes
por: Zhang, Mengdi, et al.
Publicado: (2022) -
Dynamic Metabolism in Immune Response
por: Al-Hommrani, Mazen, et al.
Publicado: (2016) -
Instruction of Immunometabolism by Adipose Tissue: Implications for Cancer Progression
por: Raja, Remya, et al.
Publicado: (2021)